跳至主要内容
临床试验/ACTRN12622000249752
ACTRN12622000249752尚未招募未知

A randomised, controlled trial of the efficacy and safety of Eye Movement Desensitisation and Reprocessing via telehealth compared with in person in Australian veterans with Posttraumatic Stress Disorder

Concord Repatriation General Hospital0 个研究点目标入组 60 人开始时间: 2022年2月11日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Australian veterans attending the National Centre for Veterans' Healthcare (NCVH)
  • 2. Department of Veterans’ Affairs (DVA) accepted clinical diagnosis of PTSD, which have been confirmed by NCVH clinicians administering and trained in the Structured Clinical Interview for DSM 5 (SCID-5)
  • 3. Suitable for treatment with EMDR

排除标准

  • 1.No prior treatment with EMDR
  • 2.No history of acquired brain injury from any cause, which may increase the risk of developing PTSD but the impact of acquired brain injury on treatment for PTSD with EMDR is currently unknown
  • 3.No active alcohol, benzodiazepine, or illicit substance use, which are common comorbidities among patients with PTSD but are generally considered relative contraindications for EMDR on the basis of their effects on long term potentiation

研究者

相似试验